Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus
Authors
Keywords
-
Journal
Viruses-Basel
Volume 11, Issue 3, Pages 254
Publisher
MDPI AG
Online
2019-03-14
DOI
10.3390/v11030254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenicity and protective efficacy of recombinant fiber-2 protein in protecting SPF chickens against fowl adenovirus 4
- (2018) Li Chen et al. VACCINE
- Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge
- (2017) Ran Zhao et al. VACCINE
- Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
- (2017) Ming Yang et al. Scientific Reports
- Genome sequence and origin analyses of the recombinant novel IBV virulent isolate SAIBK2
- (2016) Xuan Wu et al. VIRUS GENES
- Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA)
- (2016) Jin-Yong Noh et al. PLoS One
- Assembly and immunogenicity of baculovirus-derived infectious bronchitis virus–like particles carrying membrane, envelope and the recombinant spike proteins
- (2015) Peng-wei Xu et al. BIOTECHNOLOGY LETTERS
- Serotype shift of a 793/B genotype infectious bronchitis coronavirus by natural recombination
- (2015) Tingting Zhang et al. INFECTION GENETICS AND EVOLUTION
- Progress and Challenges toward the Development of Vaccines against Avian Infectious Bronchitis
- (2015) Faruku Bande et al. Journal of Immunology Research
- Virus-Like Particle Vaccine Confers Protection against a Lethal Newcastle Disease Virus Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals
- (2014) Jae-Keun Park et al. Clinical and Vaccine Immunology
- Newcastle disease virus: Current status and our understanding
- (2014) Ketan Ganar et al. VIRUS RESEARCH
- Subviral particle as vaccine and vaccine platform
- (2014) Ming Tan et al. Current Opinion in Virology
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins
- (2013) Genmei Liu et al. VACCINE
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens
- (2011) S. Kumar et al. JOURNAL OF VIROLOGY
- A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge
- (2011) W. Phoolcharoen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assembly and Biological and Immunological Properties of Newcastle Disease Virus-Like Particles
- (2010) L. W. McGinnes et al. JOURNAL OF VIROLOGY
- Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
- (2010) Emily M. Plummer et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics
- (2008) Shunlin Hu et al. VACCINE
- F gene recombination between genotype II and VII Newcastle disease virus
- (2007) Zhuoming Qin et al. VIRUS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started